Quick Asked: Wesana Contact Us?

Are you searching for Wesana Contact Us? By using our below available official links ( which are always up to date), you can find contact information without any difficulty. It may list Phone number, Mobile phone, Email Address & Customer service information.
Last update: 03 May, 2024 100 Views

Listing Results Wesana Contact Us? Question Answers

Wesana Health Commences Trading on the CSE Psychedelic

212-896-1267 For more information, please contact: Investor Contact: Allison Soss KCSA Strategic Communications Email: [email protected] Phone: 212-896-1267 Media Contact: Nick Opich / Brittany Tibaldi KCSA Strategic Communications Email: Wesana@kcsa.com Phone: 212-896-1206 / 347-487-6794 On behalf of the Board of Directors:

Wesana Health Holdings Inc. CSE Canadian Securities

Wesana Health is an emerging life sciences company championing the development and delivery of psychedelic and naturally-sourced therapies to treat traumatic brain injury (TBI). Through extensive clinical research and academic partnerships, Wesana Health is developing evidence-based formulations and protocols that empower patients to overcome neurological, ...

Daniel Carcillo Wesana Health ZoomInfo.com

Wesana Health is an emerging life sciences company championing the development and delivery of psychedelic and naturally-sourced therapies to treat traumatic brain injury (TBI). Through extensive clinical research and academic partnerships, Wesana He

WeSana Health Crunchbase Company Profile & Funding

856-986-1313 Phone Number 856-986-1313 WeSana Health is a life sciences company that provides advancement of psilocybin-based medicine. The company was founded in 2020 by Daniel Carcillo and is headquartered in Homer Glen, Illinois, United States. Lists Featuring This Company Midwestern US Health Care Companies (Top 10K)

Wesana Health Commits Funding of $1.5 Million To Support

212-896-1206 For more information, please contact: Media Contact: Nick Opich / Annie Graf KCSA Strategic Communications Email: Wesana@kcsa.com Phone: 212-896-1206 / 786-390-2644. On behalf of the Board of Directors: Daniel Carcillo, Chief Executive Officer Phone: (773) 236-7972. Source: Wesana Health Released September 14, 2021

Wesana Health

Wesana Health is creating and deploying therapies to improve how we treat the brain. Through our clinical research and academic partnerships, we’re developing new ways to help overcome neurological and psychological challenges. Our focus. TBI. At least 1.4 million cases of TBI occur each year in the US, with symptoms such as memory loss

Wesana Health Announces Closing of PsyTech Acquisition

Wesana Health Announces Closing of PsyTech Acquisition. CHICAGO and TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE: WESA, OTCQB: WSNAF

MAPS and Wesana Health Resume Negotiations Financial Post

773-236-7972 For more information, please contact: Investor Contact: Keenan Gentry Email: [email protected] Phone: 773-236-7972. Media Contacts: Nick Opich / Fallon Carter KCSA Strategic Communications Email: Wesana@kcsa.com Phone: 212-896-1206. On behalf of the Board of Directors: Daniel Carcillo, Chief Executive Officer Phone: 773-236-7972

MAPS and Wesana Health Resume Negotiations

773-236-7972 For more information, please contact: Investor Contact: Keenan Gentry Email: [email protected] Phone: 773-236-7972. Media Contacts: Nick Opich / Fallon Carter KCSA Strategic Communications Email: Wesana@kcsa.com Phone: 212-896-1206. On behalf of the Board of Directors: Daniel Carcillo, Chief Executive Officer Phone: 773-236-7972

Wasana Mobile Buy Smart Phones and Accessories Online

Apple iPhone 13 pro max 256gb Sierra Blue mobile phone with Apple Care Warranty. Highlights: Camera: 12 MP + 12 MP + 12 MP. Display size 6.7 inches (17.01 cm) Performance Apple A15 Bionic. Storage 256GB. Launch Date September 14, ...

Wesana Health Holdings Inc. Newsfile

Debut Diamonds Announces Reverse Takeover Transaction with Wesana Health and Brokered Financing Led by Stifel GMP. Toronto, Ontario--(Newsfile Corp. - February 2, 2021) - Debut Diamonds Inc. (CSE: DDI) ("Debut Diamonds" or the "Company") announces that it has entered into a binding agreement (the "Agreement") dated February 2, 2021 with WeSana ...

The World Boxing Council and Wesana Health Announce Multi

212-896-1267 For more information, please contact: Investor Contact: Allison Soss KCSA Strategic Communications Email: [email protected] Phone: 212-896-1267 Media Contact: Nick Opich / Annie Graf KCSA Strategic Communications Email: Wesana@kcsa.com Phone: 212-896-1206 / 786-390-2644 On behalf of the Board of Directors: Daniel Carcillo, Chief ...

Wesana Health Reports Q3 2021 Financial Results

773-236-7972 For more information, please contact: Investor Contact: Keenan Gentry Email: [email protected] Phone: 773-236-7972. Media Contacts: Nick Opich / Fallon Carter KCSA Strategic Communications Email: Wesana@kcsa.com Phone: 212-896-1206. On behalf of the Board of Directors: Daniel Carcillo, Chief Executive Officer Phone: 773-236-7972

Wesana Completes Filing of PCT Patents for Novel Drug

212-896-1206 Contact Us . Contact Us Email: Wesana@kcsa.com Phone: 212-896-1206. On behalf of the Board of Directors: Daniel Carcillo, Chief Executive Officer Phone: 773-236-7972. Recommended Stories.

Wesana Health Announces Listing on OTCQB® Venture Market

773-236-7972 For more information, please contact: Investor Contact: Keenan Gentry Email: [email protected] Phone: 773-236-7972. Media Contact: Nick Opich / Annie Graf KCSA Strategic Communications Email: Wesana@kcsa.com Phone: 212-896-1206 / 786-390-2644. On behalf of the Board of Directors: Daniel Carcillo, Chief Executive Officer Phone: (773) 236-7972

Wesana Health Expands Research Leadership Team with Mark

212-896-1267 Phone: 212-896-1267 Media Contact: Nick Opich / Annie Graf KCSA Strategic Communications Email: Wesana@kcsa.com Phone: 212-896-1206 / 786-390-2644 On behalf of the Board of Directors: Daniel Carcillo, Chief Executive Officer Phone: (773) 236-7972

Wesana Health to Present at the KCSA Psychedelics Virtual

For more information about the conference, or to schedule a one-on-one meeting with Wesana's management team, please contact KCSA Strategic Communications at Wesana@kcsa.com About Virtual Investor

Did the information help you? If so, please share!
If you think the information on this page has been helpful to you, would you be willing to share it? Your sharing is the driving force for our continuous work.